We then analyzed SLC2A1 mRNA expression using BRCA (Breast Cancer) datasets and TCGA breast cancer datasets (FDR = 1.9 × 10−11, Figure 1E) and the GEPIA database (Figure 1F). This evidence concerns the gene SLC2A1 and breast carcinoma.